Unknown PHASE4 INTERVENTIONAL 2-arm NCT01764867

Algorithm Guided Treatment Strategies for Major Depressive Disorder (AGTs-MDD)

Sponsor: Shanghai Mental Health Center

Interventions Bupropion Citalopram Duloxetine Escitalopram Fluoxetine Fluvoxamine Mirtazapine Paroxetine Sertraline Trazodone Venlafaxine modified electroconvulsive therapy repetitive transcranial magnetic stimulation

Updated 5 times since 2017 Last updated: Jan 8, 2013 Started: Jun 30, 2012 Primary completion: Oct 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Major Depressive Disorder and is currently ongoing. Shanghai Mental Health Center leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai Mental Health Center

Data source: Shanghai Mental Health Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China